These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 22937879)
1. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons. Balestra B; Vicini R; Cremon C; Zecchi L; Dothel G; Vasina V; De Giorgio R; Paccapelo A; Pastoris O; Stanghellini V; Corinaldesi R; De Ponti F; Tonini M; Barbara G Neurogastroenterol Motil; 2012 Dec; 24(12):1118-e570. PubMed ID: 22937879 [TBL] [Abstract][Full Text] [Related]
2. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857 [TBL] [Abstract][Full Text] [Related]
3. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712 [TBL] [Abstract][Full Text] [Related]
4. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012 [TBL] [Abstract][Full Text] [Related]
5. Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients. Buhner S; Li Q; Berger T; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Schemann M Neurogastroenterol Motil; 2012 Dec; 24(12):1134-e572. PubMed ID: 22963673 [TBL] [Abstract][Full Text] [Related]
6. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815 [TBL] [Abstract][Full Text] [Related]
7. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship? Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080 [TBL] [Abstract][Full Text] [Related]
8. Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome. Han W; Wang Z; Lu X; Guo C Neurogastroenterol Motil; 2012 Feb; 24(2):113-9, e82. PubMed ID: 22151913 [TBL] [Abstract][Full Text] [Related]
9. Irritable bowel syndrome: is the colonic mucosa to blame? Hoffman JM Neurogastroenterol Motil; 2012 Dec; 24(12):1051-3. PubMed ID: 23176660 [TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome. Willot S; Gauthier C; Patey N; Faure C Neurogastroenterol Motil; 2012 Aug; 24(8):734-9, e347. PubMed ID: 22625872 [TBL] [Abstract][Full Text] [Related]
11. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome. Dothel G; Barbaro MR; Boudin H; Vasina V; Cremon C; Gargano L; Bellacosa L; De Giorgio R; Le Berre-Scoul C; Aubert P; Neunlist M; De Ponti F; Stanghellini V; Barbara G Gastroenterology; 2015 May; 148(5):1002-1011.e4. PubMed ID: 25655556 [TBL] [Abstract][Full Text] [Related]
12. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702 [TBL] [Abstract][Full Text] [Related]
13. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556 [TBL] [Abstract][Full Text] [Related]
14. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells. Vivinus-Nébot M; Dainese R; Anty R; Saint-Paul MC; Nano JL; Gonthier N; Marjoux S; Frin-Mathy G; Bernard G; Hébuterne X; Tran A; Theodorou V; Piche T Am J Gastroenterol; 2012 Jan; 107(1):75-81. PubMed ID: 21931380 [TBL] [Abstract][Full Text] [Related]
15. Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients. Hughes PA; Moretta M; Lim A; Grasby DJ; Bird D; Brierley SM; Liebregts T; Adam B; Blackshaw LA; Holtmann G; Bampton P; Hoffmann P; Andrews JM; Zola H; Krumbiegel D Brain Behav Immun; 2014 Nov; 42():191-203. PubMed ID: 25063707 [TBL] [Abstract][Full Text] [Related]
16. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Piche T; Saint-Paul MC; Dainese R; Marine-Barjoan E; Iannelli A; Montoya ML; Peyron JF; Czerucka D; Cherikh F; Filippi J; Tran A; Hébuterne X Gut; 2008 Apr; 57(4):468-73. PubMed ID: 18194987 [TBL] [Abstract][Full Text] [Related]
17. Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome. Meira de-Faria F; Casado-Bedmar M; Mårten Lindqvist C; Jones MP; Walter SA; Keita ÅV Neurogastroenterol Motil; 2021 Nov; 33(11):e14130. PubMed ID: 33797165 [TBL] [Abstract][Full Text] [Related]
18. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS. Di Nardo G; Barbara G; Cucchiara S; Cremon C; Shulman RJ; Isoldi S; Zecchi L; Drago L; Oliva S; Saulle R; Barbaro MR; Stronati L Neurogastroenterol Motil; 2014 Feb; 26(2):196-204. PubMed ID: 24304324 [TBL] [Abstract][Full Text] [Related]
19. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358 [TBL] [Abstract][Full Text] [Related]
20. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]